Effect of PLC-β1/CaM signaling pathway mediated by AT1R on the occurrence and development of hepatocellular carcinoma

Abstract

Objective To study the roles of AT1R, PLC-β1, CaM and other related signal molecules in the formation and development of hepatocellular carcinoma (HCC) and their correlation. Methods ELISA and immunohistochemistry were used to analyze the expressions of target proteins in serum and liver tissue of HCC patients, and the correlation between AT1R, PLC-β1 and CaM and postoperative survival status of patients was followed up and determined. CCK-8 method was used to screen the doses of Ang II and candesartan sensitive to HepG2 and HCCLM3 cells. Transwell experiment was used to observe the effects of different drugs on the migration and invasion activity of HCC cells. Meanwhile, flow cytometry and Western blot were used to detect the expression levels of AT1R, PLC-β1 and CaM in the cells. Then PLC-β1 siRNA was selected to transfect HCC cells, so as to further clarify the mechanism of the above signal proteins. HepG2 cells were inoculated under the hepatic capsule of mice to induce the formation of HCC in situ. Ang II and candesartan were used to stimulate HCC mice to observe the difference in liver appearance and measure the liver index. Finally, ELISA and immunofluorescence experiments were selected to analyze the levels of target proteins in mouse serum and liver tissue. Results The expression levels of target proteins in serum and liver tissue of HCC patients were significantly increased, and the postoperative survival time of patients with high expression of AT1R, PLC-β1 or CaM was obviously shortened. Ang II and candesartan could significantly promote and inhibit the motility of HCC cells, and had different effects on the levels of AT1R, PLC-β1 and CaM in cells. However, in hepatocellular carcinoma cells transfected with PLC-β1 siRNA, the intervention ability of drugs was obviously weakened. Ang II could significantly promote the formation and progression of mouse HCC, while candesartan had the opposite effect. Meanwhile, medications could affect the expressions of target proteins in mouse serum and liver tissue. Conclusion AT1R, PLC-β1 and CaM may be risk factors affecting the formation and prognosis of HCC, and the PLC-β1/CaM signaling pathway mediated by AT1R is an important way to regulate the migration and invasion activity of HCC cells.

Identifying SCC Lesions Capable of Spontaneous Regression by Using Immunohistochemistry: A Systematic Review and Meta-Analysis Study

“…Although the activation of AT1R has homeostatic effects, studies suggest its role and expression in different types of malignancies [ 79 ]. Also, a number of studies have investigated its expression on cancerous cells, revealing AT1R’s role in tumor genesis [ 80 ]. Consistent with this implication, several treatment approaches were utilized for the management of a number of malignancies, and the results were promising [ 81 , 82 ].…”

Single-Cell Transcriptomic and Targeted Genomic Profiling Adjusted for Inflammation and Therapy Bias Reveal CRTAM and PLCB1 as Novel Hub Genes for Anti-Tumor Necrosis Factor Alpha Therapy Response in Crohn’s Disease

“…Gene PLCB1 is a member of the phospholipase family and plays a role in intracellular manifestations of extracellular signals [ 84 ]. Gene PLCB1 has been reported to be involved in the pathogenesis of neurological diseases and also as cancer-promoting in various tumors, including colorectal cancer [ 85 , 86 , 87 , 88 , 89 , 90 , 91 ]. Interestingly, PLCB1 was also identified in the blood methylome analysis of hidradenitis suppurativa (HS) patients [ 92 ].…”

The roles of phospholipase C-β related signals in the proliferation, metastasis and angiogenesis of malignant tumors, and the corresponding protective measures

“…In cell signal transduction, phosphatidylinositol-4,5-bisphosphate (PIP2) can be hydrolyzed by the activated PLC-b to generate the second messenger diglyceride (DAG) and inositol-1,4,5-triphosphate (IP3). Among them, IP3 diffuses freely and binds to IP3-specific receptors, which leads to the release of intracellular Ca 2+ , while DAG activates protein kinase C (PKC) together with Ca 2+ (Figure 1) (3).…”